Lexicon Pharmaceuticals

About Lexicon Pharmaceuticals

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to pioneering medicines that transform patients' lives through a unique application of gene science and precision science.

Products & Services

Inpefa:A product offered by Lexicon Pharmaceuticals, with further details available on the products page.

Zynquista:A medication for Type 1 Diabetes, with recent updates on data submission to the U.S. FDA regarding its benefit-risk profile.

Pilavapadin:A treatment providing meaningful pain reduction for adults with Diabetic Peripheral Neuropathic Pain (DPNP), with data presented at medical conferences.

Specialties

Gene Science Precision Science Neuropathic Pain Cardiometabolic Therapies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering and Private Placement T: - FT: Public Offering and Private Placement	A: 94600000 MR: - FA: approximately $94.6 million FAN: 94600000	D: 2026-02-02 FD: 2026-02-02	4 investors
2	RT: Public Offering and Private Placement T: - FT: Public Offering and Private Placement	A: 94600000 MR: - FA: Approximately $94.6 million FAN: 94600000	D: 2026-01-30 FD: 2026-01-30	4 investors
3	RT: Private Placement T: - FT: Private Placement	A: 250000000 MR: - FA: approximately $250 million FAN: 250000000	D: 2024-03-11 FD: 2024-03-11	5 investors
4	RT: Public Offering and Concurrent Private Placement T: - FT: Public Offering and Concurrent Private Placement	A: 71500000 MR: - FA: $71.5 million FAN: 71500000	D: 2023-06-05 FD: 2023-06-05	4 investors
5	RT: Public Offering and Private Placement T: - FT: Public Offering and Private Placement	A: 125000000 MR: - FA: $125 Million FAN: 125000000	D: 2023-06-01 FD: 2023-06-01	4 investors

Public Offering and Private Placement Latest

2026-02-02

$94.6M

4 investors (Pro only)

Public Offering and Private Placement 2026-01-30

$94.6M

Private Placement 2024-03-11

$250.0M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Scott Coiante

Senior Vice President and Chief Financial Officer

B

Brian Crum

Senior Vice President and General Counsel

L

Lisa DeFrancesco

Senior Vice President, Investor Relations and Corporate Communications

M

Mike Exton, Ph.D.

Chief Executive Officer and Director

S

Suma Gopinathan, Ph.D.

Senior Vice President, Discovery

C

Craig Granowitz, MD, PhD

Senior Vice President and Chief Medical Officer

View 5 more team members with Pro

Unlock Full Team Directory

Recent News